Pharmaceutical News

Alligator’s Mitazalimab Shows Promise in Pancreatic Cancer Treatment Introduction Alligator Bioscience, a Sweden-based biotech company, recently presented promising results from its Phase II readout of mitazalimab, a monoclonal antibody, in combination with mFOLFIRINOX chemotherapy for the treatment of pancreatic cancer. The data was published in the Lancet Oncology on June 3, 2024, and the study […] More